August 11, 2014 — Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators (CRT-D). The quadripolar lead and devices will be broadly available to physicians in mid-September.

August 11, 2014 — Toshiba America Medical Systems is making it possible for clinicians to use ultrasound to see the smallest vessels in and around areas like tumors and lymph nodes, giving them a new way to diagnose disease faster and noninvasively.

August 11, 2014 — NeoCoil LLC announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new stand-alone wireless headphones and patient alert system. The NeoCoil wireless two-way audio system is NeoCoil's first wireless patient communication and entertainment system designed specifically to work in the magnetic resonance imaging (MRI) environment.

Imaging experts from the American Society of Echocardiography (ASE) released a paper, "Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from the American Society of Echocardiography,” to help clinicians optimize and demystify the use of ultrasound contrast media.


SynCardia Systems Inc. received approval in July from the U.S. Federal Drug Administration (FDA) for the SynCardia temporary Total Artificial Heart with SynHall valves, giving the company control over the last key component to manufacture the Total Artificial Heart

Subscribe Now